Jason E. Farrar

Outlier Gene Set Analysis Combined with Top Scoring Pair Provides Robust Biomarkers of Pathway Activity

Michael F. Ochs, Michael Considine, Soheil Meschinchi, 2013, PRIB.

Outlier Analysis and Top Scoring Pair for Integrated Data Analysis and Biomarker Discovery

Michael F. Ochs, Soheil Meschinchi, Jason E. Farrar, 2014, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

Ribosomal protein genes RPS10 and RPS26 are commonly mutated in Diamond-Blackfan anemia.

Jason E. Farrar, P. Newburger, R. Arceci, 2009, American journal of human genetics.

Untangling the phenotypic heterogeneity of Diamond Blackfan anemia.

Jason E. Farrar, N. Dahl, J. Farrar, 2011, Seminars in hematology.

CSF3R mutations have a high degree of overlap with CEBPA mutations in pediatric AML.

Jason E. Farrar, D. Gerhard, M. Marra, 2016, Blood.

Plenary paper Abnormalities of the large ribosomal subunit protein, Rpl35a, in Diamond-Blackfan anemia

Jason E. Farrar, P. Meltzer, R. Arceci, 2008 .

Molecular convergence in ex vivo models of Diamond-Blackfan anemia.

Jason E. Farrar, A. Elkahloun, D. Bodine, 2017, Blood.

A multicenter, randomized study of decitabine as epigenetic priming with induction chemotherapy in children with AML

Jason E. Farrar, David W. Lee, J. Carpten, 2017, bioRxiv.

L‐leucine improves anemia and growth in patients with transfusion‐dependent Diamond‐Blackfan anemia: Results from a multicenter pilot phase I/II study from the Diamond‐Blackfan Anemia Registry

Jason E. Farrar, Ellen V. Muir, G. Nalepa, 2020, Pediatric blood & cancer.

Increased Prevalence of Congenital Heart Disease in Children With Diamond Blackfan Anemia Suggests Unrecognized Diamond Blackfan Anemia as a Cause of Congenital Heart Disease in the General Population: A Report of the Diamond Blackfan Anemia Registry

Jason E. Farrar, I. Dianzani, K. Onel, 2018, Circulation. Genomic and precision medicine.